EMCDDA: 30 years
Description
The source data for this graphic is available in the source table on this page.
Date | Description | Label |
---|---|---|
1993 | Institutional | Adoption and entry into force of Council Regulation establishing the EMCDDA |
1994 | Cooperation | First meetings of the EMCDDA Management Board, Scientific Committee and Reitox network |
1995 | Institutional | EMCDDA opens in Lisbon under its first Director Georges Estievenart |
1996 | Drug situation | First Annual report on the state of the drugs problem in Europe |
1997 | NPS | Early Warning System on new synthetic drugs established |
1998 | NPS | MBDB becomes the first new synthetic drug risk assessed |
1999 | NPS | 4-MTA is the first new synthetic drug brought under control following risk assessment |
2000 | Responses | Evaluation Instruments Bank launched online offering tools for evaluating drug-related interventions |
2001 | Cooperation | Norway joins the EMCDDA |
2002 | Drug situation | First report on the drug situation in the candidate Central and Eastern European Countries |
2003 | Cooperation | Reitox Operating Framework adopted |
2004 | Cooperatoin | 10 new Member States join the EMCDDA following EU enlargement |
2005 | Institutional | Wolfgang Götz takes up post as Director |
2006 | Events | President of the European Commission José Manuel Durão Barroso visits EMCDDA |
2007 | Cooperation | Bulgaria and Romania join the agency following EU enlargement |
2008 | Responses | Best practice portal launched |
2009 | Events | Conference ‘Identifying Europe’s information needs for effective drug policy’ |
2010 | Events | First European conference on drug supply indicators |
2011 | Markets | Trendspotter meeting on recent shocks in the European heroin market |
2012 | Training | First European Drugs Summer School (EMCDDA–ISCTE) |
2013 | Markets | First EU Drug Markets Report (EMCDDA–Europol) |
2014 | Cooperation | Turkey joins the EMCDDA |
2015 | Events | First Lisbon Addictions conference |
2016 | Institutional | Alexis Goosdeel takes up post as Director |
2017 | Responses | First Health and social responses to drug problems: a European guide |
2018 | NPS | New legislation brings faster response to new drugs |
2019 | Responses | Agency launches standardised prevention training curriculum |
2020 | Training | EMCDDA webinars series launched |
2021 | Institutional | Development of a new EMCDDA business model |
2022 | NPS | 25 years of the EU Early Warning System on NPS |
2023 | Institutions | Preparations for a new mandate paving the way for the European Union Drugs Agency |